BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35840716)

  • 21. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
    Mishra KK; Daftari IK; Weinberg V; Cole T; Quivey JM; Castro JR; Phillips TL; Char DH
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):330-6. PubMed ID: 23886415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
    Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG
    Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histopathologic study of eyes after iodine I 125 episcleral plaque irradiation for uveal melanoma.
    Saornil MA; Fisher MR; Campbell RJ; Robertson DM; Earle JD; Eagle RC; Shields JA; Shields CL; Chandra SR; Albert DM
    Arch Ophthalmol; 1997 Nov; 115(11):1395-400. PubMed ID: 9366669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of plaque brachytherapy and proton beam radiotherapy on prognostic testing: a comparison of uveal melanoma genotyped by microsatellite analysis.
    Thornton S; Coupland SE; Heimann H; Hussain R; Groenewald C; Kacperek A; Damato B; Taktak A; Eleuteri A; Kalirai H
    Br J Ophthalmol; 2020 Oct; 104(10):1462-1466. PubMed ID: 32024655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uveal tumour resection.
    Char DH; Miller T; Crawford JB
    Br J Ophthalmol; 2001 Oct; 85(10):1213-9. PubMed ID: 11567967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumour cell proliferation after failed ruthenium plaque radiotherapy for posterior uveal melanoma.
    Seregard S; Lundell G; Lax I; af Trampe E; Kock E
    Acta Ophthalmol Scand; 1997 Apr; 75(2):148-54. PubMed ID: 9197561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of high-frequency ultrasound imaging to improve delineation of anterior uveal melanoma for proton irradiation.
    Daftari I; Barash D; Lin S; O'Brien J
    Phys Med Biol; 2001 Feb; 46(2):579-90. PubMed ID: 11229735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Outcomes of Proton Radiotherapy for Uveal Melanoma.
    Verma V; Mehta MP
    Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):e17-27. PubMed ID: 26915706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uveal Melanoma Metastasis to the Contralateral Eye Structures: A Retrospective Comparative Analysis of 13 Consecutive Patients.
    Masoomian B; Mashayekhi A; Shields JA; Shields CL
    Ophthalmol Retina; 2021 Oct; 5(10):1036-1042. PubMed ID: 33421627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scleral necrosis after plaque radiotherapy of uveal melanoma: a case-control study.
    Kaliki S; Shields CL; Rojanaporn D; Badal J; Devisetty L; Emrich J; Komarnicky L; Shields JA
    Ophthalmology; 2013 May; 120(5):1004-11. PubMed ID: 23347983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitreoretinal Surgery in the Prevention and Treatment of Toxic Tumour Syndrome in Uveal Melanoma: A Systematic Review.
    Romano MR; Catania F; Confalonieri F; Zollet P; Allegrini D; Sergenti J; Lanza FB; Ferrara M; Angi M
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Episcleral plaque radiotherapy for uveal melanoma.
    Giblin ME; Shields JA; Augsburger JJ; Brady LW
    Aust N Z J Ophthalmol; 1989 May; 17(2):153-6. PubMed ID: 2667581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uveal melanoma: management and outcome of patients with extraocular spread.
    Bellmann C; Lumbroso-Le Rouic L; Levy C; Plancher C; Dendale R; Sastre-Garau X; Asselain B; Desjardins L
    Br J Ophthalmol; 2010 May; 94(5):569-74. PubMed ID: 19965816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plaque radiotherapy for choroidal and ciliochoroidal melanomas with limited nodular extrascleral extension.
    Augsburger JJ; Schneider S; Narayana A; Breneman JC; Aron BS; Barrett WL; Trichopoulos N
    Can J Ophthalmol; 2004 Jun; 39(4):380-7. PubMed ID: 15327103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation therapy for uveal melanomas involving the ciliary body.
    Char DH
    Trans Ophthalmol Soc U K (1962); 1986; 105 ( Pt 2)():252-6. PubMed ID: 3467500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrasonography and transillumination for uveal melanoma localisation in proton beam treatment planning.
    Lu JE; Welch RJ; Mishra KK; Daftari IK; Park SS
    Eye (Lond); 2019 Dec; 33(12):1904-1910. PubMed ID: 31278380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A clinicopathological study of seven globes enucleated after primary radiation therapy for malignant melanoma of the choroid or ciliary body.
    Liszauer AD; Brownstein S; Corriveau C; DeschĂȘnes J
    Can J Ophthalmol; 1990 Dec; 25(7):340-4. PubMed ID: 2090338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton Beam Irradiation: A Safe Procedure in Postequatorial Extraocular Extension From Uveal Melanoma.
    Seibel I; Riechardt AI; Erb-Eigner K; Böker A; Cordini D; Heufelder J; Joussen AM
    Am J Ophthalmol; 2018 Jul; 191():49-53. PubMed ID: 29655645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy of malignant melanoma of the uvea with I-125 seeds.
    Heikkonen J; Summanen P; Immonen I; Tommila P; Toivola H; Forss M; Tarkkanen A
    Acta Ophthalmol (Copenh); 1992 Dec; 70(6):780-5. PubMed ID: 1488887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.